Tel Aviv University 
Welcome,         Profile    Billing    Logout  
 1 Product   0 Diseases   1 Product   1 Trial   8471 News 


«12...57585960616263646566676869»
  • ||||||||||  NurOwn (MSC-NTF) / BrainStorm Cell Therap
    Enrollment closed, Enrollment change, Trial completion date, Trial primary completion date:  Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients (clinicaltrials.gov) -  Oct 30, 2019   
    P3,  N=261, Active, not recruiting, 
    Recruiting --> Active, not recruiting | N=200 --> 261 | Trial completion date: Jul 2020 --> Dec 2020 | Trial primary completion date: Jul 2019 --> Oct 2020
  • ||||||||||  NurOwn (MSC-NTF) / BrainStorm
    Disability Improvement Assessed by Multiple Sclerosis Functional Composite in Progressive MS Patients from the CLIMB Study (Poster Exhibition) -  Aug 28, 2019 - Abstract #ECTRIMS2019ECTRIMS_1580;    
    P2
    9HPT and T25FW provide alternative measures of disability improvement in MS patients. A small proportion (~6%) of progressive MS patients experience ≥ 25% improvement in these measures over 12 months, this may serve as a benchmark for new therapeutic strategies and will inform analysis of clinical outcomes in the ongoing phase 2 clinical trial of MSC-NTF cells in progressive MS.
  • ||||||||||  NurOwn (MSC-NTF) / BrainStorm Cell Therap
    Enrollment open:  Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS (clinicaltrials.gov) -  Jul 8, 2019   
    P2,  N=20, Recruiting, 
    A small proportion (~6%) of progressive MS patients experience ≥ 25% improvement in these measures over 12 months, this may serve as a benchmark for new therapeutic strategies and will inform analysis of clinical outcomes in the ongoing phase 2 clinical trial of MSC-NTF cells in progressive MS. Not yet recruiting --> Recruiting
  • ||||||||||  NurOwn (MSC-NTF) / BrainStorm Cell Therap
    Trial completion date, Trial primary completion date:  Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients (clinicaltrials.gov) -  Mar 26, 2019   
    P3,  N=200, Recruiting, 
    Not yet recruiting --> Recruiting Trial completion date: Jul 2019 --> Jul 2020 | Trial primary completion date: Apr 2019 --> Jul 2019